{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T15:28:04Z","timestamp":1781796484205,"version":"3.54.5"},"reference-count":65,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T00:00:00Z","timestamp":1750118400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>IgG4-related pancreatitis (IRP) is a form of chronic pancreatitis characterized by the infiltration of IgG4-positive plasma cells, representing a pancreatic manifestation of IgG4-related disease (IgG4-RD). In recent years, with the growing understanding of IgG4-RD, the incidence of IRP has shown an increasing trend. This article provides a comprehensive review of the latest advancements in the epidemiology, etiology, pathogenesis, clinical manifestations, diagnosis, differential diagnosis, and treatment of IRP.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1590902","type":"journal-article","created":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T05:27:51Z","timestamp":1750138071000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["A comprehensive review of IgG4-related pancreatitis: pathogenesis, diagnosis, and therapeutic advances"],"prefix":"10.3389","volume":"16","author":[{"given":"Siqin","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowen","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenjing","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanlan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1002\/ueg2.12237","article-title":"Unraveling the relationship between autoimmune pancreatitis type 2 and inflammatory bowel disease: Results from two centers and systematic review of the literature","volume":"10","author":"Nikolic","year":"2022","journal-title":"United Eur Gastroenterol J"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-019-01658-7","article-title":"Nationwide epidemiological survey of autoimmune pancreatitis in Japan in 2016","volume":"55","author":"Masamune","year":"2020","journal-title":"J Gastroenterol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2016.90","article-title":"Sex differences in immune responses","volume":"16","author":"Klein","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.693192","article-title":"Allergic aspects of igG4-related disease: implications for pathogenesis and therapy","volume":"12","author":"Michailidou","year":"2021","journal-title":"Front Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1080\/25785826.2024.2407224","article-title":"The immunological pathogenesis of IgG4-related disease categorized by clinical characteristics","volume":"48","author":"Akiyama","year":"2025","journal-title":"Immunol Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-020-0500-7","article-title":"IgG4-related disease: an update on pathophysiology and implications for clinical care","volume":"16","author":"Perugino","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"102646","DOI":"10.1016\/j.autrev.2020.102646","article-title":"Update on IgG4-mediated autoimmune diseases: New insights and new family members","volume":"19","author":"Koneczny","year":"2020","journal-title":"Autoimmun Rev"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-050219-034449","article-title":"Clinical perspectives on igG4-related disease and its classification","volume":"73","author":"Katz","year":"2022","journal-title":"Annu Rev Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1002\/art.39209","article-title":"Number of circulating follicular helper 2 T cells correlates with igG4 and interleukin-4 levels and plasmablast numbers in igG4-related disease","volume":"67","author":"Akiyama","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s13075-016-1064-4","article-title":"Enhanced IgG4 production by follicular helper 2 T cells and the involvement of follicular helper 1 T cells in the pathogenesis of IgG4-related disease","volume":"18","author":"Akiyama","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.3154-23","article-title":"IgG4-related disease: recent topics on immunological aspects of this disorder and their application in new treatment strategies","volume":"64","author":"Kawano","year":"2025","journal-title":"Intern Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.cn141217-20230824-00050","article-title":"Advances in the pathogenesis and targeted therapy of igG4-related diseases","volume":"28","author":"Haoyan","year":"2024","journal-title":"Chin J Rheumatol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.jaci.2023.08.019","article-title":"Single-cell transcriptomics reveals granzyme K-expressing cytotoxic Tfh cells in tertiary lymphoid structures in IgG4-RD","volume":"153","author":"Aoyagi","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"670","DOI":"10.3390\/cells12040670","article-title":"Peripheral immunophenotype in igG4-related disease and its association with clinical phenotypes and disease activity","volume":"12","author":"Mart\u00edn-Nares","year":"2023","journal-title":"Cells"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1097\/MPA.0b013e3182142fd2","article-title":"International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology","volume":"40","author":"Shimosegawa","year":"2011","journal-title":"Pancreas"},{"key":"B16","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/art.41120","article-title":"The 2019 american college of rheumatology\/european league against rheumatism classification criteria for igG4-related disease","volume":"72","author":"Wallace","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.12449\/JCH240705","article-title":"Chinese guideline for the diagnosis and treatment of autoimmune pancreatitis (Shanghai, 2023)","volume":"40","author":"Zhaoshen","year":"2024","journal-title":"J Clin Hepatobiliary Diseases"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200103083441005","article-title":"High serum IgG4 concentrations in patients with sclerosing pancreatitis","volume":"344","author":"Hamano","year":"2001","journal-title":"N Engl J Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ejim.2022.03.014","article-title":"Incidence of endocrine and exocrine insufficiency in patients with autoimmune pancreatitis at diagnosis and after treatment: a systematic review and meta-analysis","volume":"100","author":"Lanzillotta","year":"2022","journal-title":"Eur J Intern Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-022-01857-9","article-title":"Amendment of the Japanese consensus guidelines for autoimmune pancreatitis, 2020","volume":"57","author":"Okazaki","year":"2022","journal-title":"J Gastroenterol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.pan.2016.02.006","article-title":"Diagnosis, treatment and long-term outcomes of autoimmune pancreatitis in Spain based on the International Consensus Diagnostic Criteria: A multi-centre study","volume":"16","author":"L\u00f3pez-Serrano","year":"2016","journal-title":"Pancreatology"},{"key":"B22","doi-asserted-by":"publisher","first-page":"258","DOI":"10.3390\/jcm8020258","article-title":"Kidney involvement in patients with type 1 autoimmune pancreatitis","volume":"8","author":"Vujasinovic","year":"2019","journal-title":"J Clin Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3390\/jcm9020409","article-title":"Cardiovascular and lung involvement in patients with autoimmune pancreatitis","volume":"9","author":"Nikolic","year":"2020","journal-title":"J Clin Med"},{"key":"B24","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.pan.2017.10.005","article-title":"Monitoring and predicting disease activity in autoimmune pancreatitis with the M-ANNHEIM-AiP-Activity-Score","volume":"18","author":"Hirth","year":"2018","journal-title":"Pancreatology"},{"key":"B25","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/j.cgh.2023.12.010","article-title":"Type 1 autoimmune pancreatitis in europe: clinical profile and response to treatment","volume":"22","author":"Overbeek","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2019.219725","article-title":"Conditions associated with polyclonal hypergammaglobulinemia in the IgG4-related disease era: a retrospective study from a hematology tertiary care center","volume":"105","author":"Zhao","year":"2020","journal-title":"Haematologica"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.pan.2024.11.018","article-title":"Serum IgG4-negative and IgG4-positive type 1 autoimmune pancreatitis present with different clinicopathological features: An analysis of a nationwide survey in Japan","volume":"25","author":"Sano","year":"2025","journal-title":"Pancreatology"},{"key":"B28","doi-asserted-by":"publisher","first-page":"6340","DOI":"10.3390\/jcm12196340","article-title":"Autoimmune pancreatitis type 1 with biliary, nasal, testicular, and pulmonary involvement: A case report and a systematic review","volume":"12","author":"Kourie","year":"2023","journal-title":"J Clin Med"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1177\/2050640620934911","article-title":"European Guideline on IgG4-related digestive disease - UEG and SGF evidence-based recommendations","volume":"8","author":"L\u00f6hr","year":"2020","journal-title":"United Eur Gastroenterol J"},{"key":"B30","doi-asserted-by":"publisher","first-page":"13341","DOI":"10.1038\/s41598-021-92814-8","article-title":"Serum IgG4 levels at diagnosis can predict unfavorable outcomes of untreated patients with IgG4-related disease","volume":"11","author":"Mizushima","year":"2021","journal-title":"Sci Rep"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.13602\/j.cnki.jcls.2023.07.09","article-title":"The clinical value of combined detection of serum igG4, CEA, CA19-9, and NLR in differentiating igG4-related autoimmune pancreatitis from pancreatic cancer","volume":"41","author":"Shuo","year":"2023","journal-title":"J Clin Laboratory"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1673-5412.2022.02.009","article-title":"Clinical value of combined detection of serum CA19-9, TAP and IgG4 in the differential diagnosis of IgG4-related autoimmune pancreatitis and pancreatic cancer","volume":"35","author":"Ruimin","year":"2022","journal-title":"Basic Clin Oncol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.pan.2018.09.003","article-title":"Diagnosis, treatment and long-term outcome of autoimmune pancreatitis in Sweden","volume":"18","author":"Vujasinovic","year":"2018","journal-title":"Pancreatology"},{"key":"B34","doi-asserted-by":"publisher","first-page":"155331","DOI":"10.1016\/j.prp.2024.155331","article-title":"Recent advances in IgG4-related autoimmune pancreatitis","volume":"257","author":"Yang","year":"2024","journal-title":"Pathol Res Pract"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1007\/s10396-021-01148-5","article-title":"Histological features of autoimmune pancreatitis and IgG4-related sclerosing cholangitis with a correlation with imaging findings","author":"Notohara","year":"2001","journal-title":"J Med Ultrason"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.13362\/j.jpmed.202401003","article-title":"Imaging manifestations of IgG4-related autoimmune pancreatitis","volume":"39","author":"Xu Bing","year":"2024","journal-title":"J Precis Med"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.4103\/EUS-D-21-00111","article-title":"Differential EUS findings in focal type 1 autoimmune pancreatitis and pancreatic cancer: A proof-of-concept study","volume":"11","author":"Tacelli","year":"2022","journal-title":"Endosc Ultrasound"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-016-1302-1","article-title":"Low-dose maintenance steroid treatment could reduce the relapse rate in patients with type 1 autoimmune pancreatitis: a long-term Japanese multicenter analysis of 510 patients","volume":"52","author":"Kubota","year":"2017","journal-title":"J Gastroenterol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1111\/den.14889","article-title":"Endoscopic ultrasonography for microvascular imaging without contrast enhancement in the differential diagnosis of pancreatic lesions","volume":"37","author":"Yamashita","year":"2025","journal-title":"Dig Endosc"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-024-04780-0","article-title":"Ultrasound-guided percutaneous core-needle biopsy for the diagnosis of type 1 autoimmune pancreatitis","author":"Zhao","year":"2025","journal-title":"Abdom Radiol (NY)"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-021-00529-y","article-title":"IgG4-related diseases of the digestive tract","volume":"19","author":"L\u00f6hr","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1055\/a-1293-7279","article-title":"Diagnostic yield of endoscopic ultrasound-guided tissue acquisition in autoimmune pancreatitis: a systematic review and meta-analysis","volume":"9","author":"Facciorusso","year":"2021","journal-title":"Endosc Int Open"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.gie.2025.02.038","article-title":"Impact of EUS-guided fine-needle biopsy on International Consensus Diagnostic Criteria for diagnosing autoimmune pancreatitis: a prospective multicenter study","author":"Conti Bellocchi","year":"2025","journal-title":"Gastrointest Endosc"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1111\/den.14885","article-title":"Comparison of clinical\/histological outcomes according to puncture sites in endoscopic ultrasound-guided fine needle biopsy for large pancreatic masses: Multicenter randomized prospective pilot study","volume":"37","author":"Ko","year":"2025","journal-title":"Dig Endosc"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1097\/CM9.0000000000001891","article-title":"Update on classification, diagnosis, and management of immunoglobulin G4-related disease","volume":"135","author":"Chen","year":"2022","journal-title":"Chin Med J (Engl)"},{"key":"B46","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s00535-022-01891-7","article-title":"Current status of type 1 (IgG4-related) autoimmune pancreatitis","volume":"57","author":"Uchida","year":"2022","journal-title":"J Gastroenterol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1002\/art.39132","article-title":"International consensus guidance statement on the management and treatment of igG4-related disease","volume":"67","author":"Khosroshahi","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pan.2016.12.003","article-title":"International consensus for the treatment of autoimmune pancreatitis","volume":"17","author":"Okazaki","year":"2017","journal-title":"Pancreatology"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1002\/ueg2.12738","article-title":"Update on autoimmune pancreatitis and igG4-related disease","volume":"13","author":"Lanzillotta","year":"2025","journal-title":"United Eur Gastroenterol J"},{"key":"B50","doi-asserted-by":"publisher","first-page":"103273","DOI":"10.1016\/j.autrev.2023.103273","article-title":"Development of an algorithm for IgG4-related disease management","volume":"22","author":"Orozco-G\u00e1lvez","year":"2023","journal-title":"Autoimmun Rev"},{"key":"B51","doi-asserted-by":"publisher","first-page":"3724","DOI":"10.3390\/jcm11133724","article-title":"Exocrine and endocrine insufficiency in autoimmune pancreatitis: A matter of treatment or time","volume":"11","author":"Nikolic","year":"2022","journal-title":"J Clin Med"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.pan.2020.07.408","article-title":"Corticosteroids prevent the progression of autoimmune pancreatitis to chronic pancreatitis","volume":"20","author":"Kuraishi","year":"2020","journal-title":"Pancreatology"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-019-04880-z","article-title":"Efficacy and safety of iguratimod on patients with relapsed or refractory IgG4-related disease","volume":"39","author":"Liu","year":"2020","journal-title":"Clin Rheumatol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1002\/acr.23543","article-title":"An international multispecialty validation study of the igG4-related disease responder index","volume":"70","author":"Wallace","year":"2018","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v29.i35.5125","article-title":"Clinical characteristics and outcome of autoimmune pancreatitis based on serum immunoglobulin G4 level: A single-center, retrospective cohort study","volume":"29","author":"Zhou","year":"2023","journal-title":"World J Gastroenterol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kev438","article-title":"Predictors of disease relapse in IgG4-related disease following rituximab","volume":"55","author":"Wallace","year":"2016","journal-title":"Rheumatol (Oxford)"},{"key":"B57","doi-asserted-by":"publisher","first-page":"6195","DOI":"10.1038\/s41598-017-06520-5","article-title":"Efficacy of Cyclophosphamide treatment for immunoglobulin G4-related disease with addition of glucocorticoids","volume":"7","author":"Yunyun","year":"2017","journal-title":"Sci Rep"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2012-302886","article-title":"Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience","volume":"62","author":"Hart","year":"2013","journal-title":"Gut"},{"key":"B59","article-title":"Advances in drug therapy for IgG4-related diseases","volume":"31","author":"Minmin","year":"2022","journal-title":"Chin J New Drugs"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-208916","article-title":"Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task force","volume":"75","author":"Strehl","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-023-06528-5","article-title":"Comparison of the efficacy and safety of leflunomide versus mycophenolate mofetil in treating IgG4-related disease: a retrospective cohort study","volume":"42","author":"Chen","year":"2023","journal-title":"Clin Rheumatol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kez380","article-title":"Glucocorticoids and steroid sparing medications monotherapies or in combination for IgG4-RD: a systematic review and network meta-analysis","volume":"59","author":"Omar","year":"2020","journal-title":"Rheumatol (Oxford)"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0183844","article-title":"Long-term efficacy and safety of rituximab in IgG4-related disease: Data from a French nationwide study of thirty-three patients","volume":"12","author":"Ebbo","year":"2017","journal-title":"PloS One"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(23)00157-1","article-title":"Evaluation of the safety, efficacy, and mechanism of action of obexelimab for the treatment of patients with IgG4-related disease: an open-label, single-arm, single centre, phase 2 pilot trial","volume":"5","author":"Perugino","year":"2023","journal-title":"Lancet Rheumatol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1097\/MPA.0000000000002484","article-title":"Usefulness and safety of endoscopic nasobiliary drainage for type 1 autoimmune pancreatitis","author":"Ito","year":"2025","journal-title":"Pancreas"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1590902\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T05:27:55Z","timestamp":1750138075000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1590902\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,17]]},"references-count":65,"alternative-id":["10.3389\/fimmu.2025.1590902"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1590902","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,17]]},"article-number":"1590902"}}